ASHP statement on the pharmacy and therapeutics committee
American Journal of Hospital Pharmacy 35(7): 813-814
1978
ISSN/ISBN: 0002-9289 PMID: 665701 Document Number: 124867
Document emailed within 1 workday
Related Documents
1992: ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. ASHP Commission on Therapeutics Clinical Pharmacy 11(6): 483-513Cohen, M.R.; Klapp, D.; Miller, K.B.; Shaffer, V.L.; Slotfeldt, M.; Miller, D.E. 1984: Improving pharmacy and therapeutics committee operations American Journal of Hospital Pharmacy 41(9): 1767-1777
Mehr, S.R. 2006: The evolutionary role of the pharmacy and therapeutics committee in technology assessment Managed Care Interface 19(1): 42-45
Lipman, A.G. 1989: Current information on the use of immunobiologics: comments of the ASHP Commission on Therapeutics Clinical Pharmacy 8(12): 850-851
1972: ASHP statement on national health insurance American Journal of Hospital Pharmacy 29(2): 157-160
Provost, G.P. 1972: Supportive personnel in hospital pharmacy. I. ASHP involvement American Journal of Hospital Pharmacy 29(3): 209
Knapp, D.A. 1992: Applause for ASHP-APhA-NARD joint statement on the entry-level degree American Journal of Hospital Pharmacy 49(3): 569
1982: ASHP supplemental standard and learning objectives for residency training in oncology pharmacy practice American Journal of Hospital Pharmacy 39(7): 1214-1215
1979: American Academy of Pediatrics. Committee on Accident and Poison Prevention and Committee on Pediatric Aspects of Physical Fitness, Recreation, and Sports. Skateboard policy statement Pediatrics 63(6): 924-925
1993: ASHP accreditation standard for pharmacy technician training programs. American Society of Hospital Pharmacists American Journal of Hospital Pharmacy 50(1): 124-126
Vanderveen, T.; Parks, R. 1981: ASHP supplemental standard and learning objectives for residency training in nutritional support pharmacy practice American Journal of Hospital Pharmacy 38(12): 1971-1973
Chang, S.; Shane, R. 1993: Pharmacy and therapeutics subcommittee on pediatrics American Journal of Hospital Pharmacy 50(10): 2086-2087
Inguanti, M.E. 2007: Automating the pharmacy and therapeutics process: driving a safer and more cost-effective future Managed Care Interface 20(3): 13-14
Skjoldan, J. 1973: Early statement from the education committee Sygeplejersken 73(24): 3
Acar, J.; Bergogne-Berezin, E.; Chabbert, Y.; Cluzel, R.; Courtieu, A.; Courvalin, P.; Dabernat, H.; Drugeon, H.; Duval, J.; Fleurette, J. 1984: Statement of the Antibiogram Committee of the French Society of Microbiology Pathologie-Biologie 32(5): 297-298
Atkinson, J.; Capdeville-Atkinson, C.; Chillon, J.M.; Giummelly, P.; Lartaud-Idjouadiene, I. 1998: Cardiovascular aging: physiology, pathology, pharmacology and therapeutics. 23-24 July 1998, Faculty of Pharmacy, Nancy, France IDrugs: the investigational drugs journal 1(6): 650-651
Cook, R.E.; Richards, T.H. 1991: The effective pharmacy-nursing committee Topics in Hospital Pharmacy Management 10(4): 31-36
Bristow, L.R. 1995: AMA statement to the House Ways and Means Committee Subcommittee on Health Journal of the Oklahoma State Medical Association 88(9): 398-401
1992: American Academy of Pediatrics Committee on Nutrition: Statement on cholesterol Pediatrics 90(3): 469-473
Yewale, V.N.; Choudhury, P. 2010: Rotavirus vaccine contamination with PCV1--statement of IAP Committee on Immunization Indian Pediatrics 47(7): 589-591